MiR-221-3p Attenuates IL-33-Induced Mast Cell Cytokine Expression by Targeting KIT

Ruowu Liu1, Jiao Zhou2, Jing Zhou1

  • 1Department of Otolaryngology-Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.

Abstract

Insights

MicroRNA-221-3p inhibits mast cell activation and type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP). This finding identifies miR-221-3p as a potential therapeutic target for CRSwNP.

Area of Science:

  • Immunology
  • Molecular Biology
  • Otorhinolaryngology

Background:

  • Mast cells (MCs) drive type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), a process influenced by interleukin-33 (IL-33).
  • MicroRNA-221 (miR-221) is implicated in MC regulation, with miR-221-3p detected in CRSwNP tissues, but its specific role remains unclear.

Purpose of the Study:

  • To investigate the role and mechanism of miR-221-3p in mast cells within the context of CRSwNP.
  • To determine if miR-221-3p modulates IL-33-induced mast cell activation and associated inflammatory responses.

Main Methods:

  • Quantitative PCR and western blotting to assess miR-221-3p, cytokine, and signaling pathway expression in CRSwNP tissues and human MCs.
  • In situ hybridization and immunofluorescence for miR-221-3p localization.
  • Luciferase reporter assays to identify miR-221-3p targets.
  • In vitro experiments using microRNA mimics/inhibitors and lentiviral vectors in IL-33-stimulated human MCs.

Main Results:

  • miR-221-3p expression was elevated in CRSwNP tissues and localized to MCs, negatively correlating with IL-4, IL-5, and IL-13.
  • IL-33 stimulation induced miR-221-3p in MCs, which then suppressed cytokine production and signaling pathways.
  • The receptor KIT, a direct target of miR-221-3p, was downregulated in CRSwNP and essential for MC response to IL-33, with miR-221-3p regulating cytokine expression via KIT targeting.

Conclusions:

  • MiR-221-3p acts as a negative regulator in CRSwNP by inhibiting MC-dependent type 2 inflammation.
  • Targeting miR-221-3p presents a potential therapeutic strategy for CRSwNP by modulating mast cell activity.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K